0001554795-18-000117.txt : 20180510 0001554795-18-000117.hdr.sgml : 20180510 20180510125011 ACCESSION NUMBER: 0001554795-18-000117 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 25 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180510 DATE AS OF CHANGE: 20180510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CANCER CAPITAL CORP CENTRAL INDEX KEY: 0001130889 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 911803648 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-32363 FILM NUMBER: 18821480 BUSINESS ADDRESS: STREET 1: 2157 S. LINCOLN STREET 2: 2157 S. LINCOLN CITY: SALT LAKE CITY STATE: UT ZIP: 84106 BUSINESS PHONE: 8013232395 MAIL ADDRESS: STREET 1: 2157 S. LINCOLN STREET 2: 2157 S. LINCOLN CITY: SALT LAKE CITY STATE: UT ZIP: 84106 10-Q 1 cncl0503form10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2018

 

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___ to ___

 

Commission file number: 000-32363

 

CANCER CAPITAL CORP.

(Exact name of registrant as specified in its charter)

 

Wyoming

(State or other jurisdiction of incorporation or organization)

91-1803648

(I.R.S. Employer Identification No.)

2157 S. Lincoln Street, Salt Lake City, Utah

(Address of principal executive offices)

84106

(Zip code)

 

(801) 323-2395

(Registrant’s telephone number, including area code)

 

The registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☑ No ☐ The registrant does not have a Web site.

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Non-accelerated filer ☐

Emerging growth company ☑

Accelerated filer ☐

Smaller reporting company ☑

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☑ No ☐

 

The number of shares outstanding of the registrant’s common stock as of May 8, 2018 was 6,150,000.

 
 

TABLE OF CONTENTS

 

  PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements (Unaudited) 2
Condensed Balance Sheets (Unaudited) 3
  Condensed Statements of Operations (Unaudited) 4
  Condensed Statements of Cash Flows (Unaudited) 5
  Condensed Notes to the Unaudited Financial Statements 6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 7
Item 3. Quantitative and Qualitative Disclosures about Market Risk 9
Item 4. Controls and Procedures 9
     
  PART II – OTHER INFORMATION  
     
Item 6. Exhibits 10
Signature 11

 

 

 

 

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

 

 

CANCER CAPITAL CORP.

 

Condensed Financial Statements

 

March 31, 2018

 

(Unaudited) 

 

 2 

 

Cancer Capital Corp.

Condensed Balance Sheets

(Unaudited)

       
   MAR 31, 2018  DEC 31, 2017
       
       
ASSETS          
CURRENT ASSETS          
Cash  $178   $315 
Total current assets   178    315 
Total assets  $178   $315 
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
CURRENT LIABILITIES          
Accounts payable – related party  $8,700   $6,600 
Accounts payable   3,475    —   
Notes payable – related party   100,525    100,525 
Notes payable   82,575    82,575 
Accrued interest – related party   28,639    26,629 
Accrued interest   29,258    27,607 
Total current liabilities   253,172    243,936 
Total liabilities   253,172    243,936 
           
STOCKHOLDERS' DEFICIT          
Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding   6,150    6,150 
Additional paid-in capital   47,050    47,050 
Accumulated deficit   (306,194)   (296,821)
Total stockholders' deficit   (252,994)   (243,621)
Total liabilities and stockholders' deficit  $178   $315 

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 3 

 

Cancer Capital Corp.

Condensed Statements of Operations

(Unaudited)

       
   FOR THE
THREE MONTHS ENDED
MAR 31, 2018		  FOR THE
THREE MONTHS
ENDED
MAR 31, 2017
       
Revenues  $—     $—   
       
Expenses          
General and administrative   5,712    5,650 
Total expenses   5,712    5,650 
           
Loss from operations before other expense   (5,712)   (5,650)
           
Other income (expense) non-operating          
Interest expense – related party   (2,010)   (1,832)
Interest expense   (1,651)   (1,561)
Total other expense   (3,661)   (3,393)
           
Loss from operations before taxes   (9,373)   (9,043)
           
Taxes   —      —   
           
Net loss  $(9,373)  $(9,043)
           
Net loss per share – Basic and diluted  $(0.00)  $(0.00)
           
Weighted average shares outstanding   6,150,000    6,150,000 

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 4 

 

Cancer Capital Corp.

Condensed Statements of Cash Flows

(Unaudited)

       
   FOR THE THREE MONTHS ENDED
MAR 31, 2018		  FOR THE THREE MONTHS ENDED
MAR 31, 2017
       
Cash Flows from Operating Activities          
Net Loss  $(9,373)  $(9,043)
Adjustment to reconcile net loss to cash provided (used) by operating activities:          
Expenses paid by related party   2,100    2,100 
Changes in operating assets and liabilities:          
Increase in Accounts payable   3,475    3,400 
Increase in Accrued interest – related party   2,010    1,832 
Increase in Accrued interest   1,651    1,561 
Net cash provided (used) by operating activities   (137)   (150)
           
Cash Flows from Investing Activities          
Net cash provided by investing activities   —      —   
           
Cash Flows from Financing Activities          
Net cash provided by financing activities   —      —   
           
Increase (decrease) in cash   (137)   (150)
           
Cash and cash equivalents at beginning of period   315    625 
           
Cash and cash equivalents at end of period  $178   $475 
           
Supplemental Cash Flow Information:          
Cash paid for interest  $—     $—   
Cash paid for income taxes  $—     $—   

 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 5 

 

Cancer Capital Corp.

Notes to the Condensed Financial Statements

(Unaudited)

March 31, 2018

 

 

NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its December 31, 2017 Annual Report on Form 10-K. Operating results for the three months ended March 31, 2018 are not necessarily indicative of the results to be expected for year ending December 31, 2018.

 

 

NOTE 2 – GOING CONCERN

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies.

 

 

NOTE 3 – RELATED PARTY TRANSACTIONS

 

During the quarter ended March 31, 2018, a shareholder invoiced the Company for consulting, administrative and professional services and out-of-pocket costs provided or paid on behalf of the Company totaling $2,100. Notes payable – related party at March 31, 2018 were $100,525. Accrued interest at March 31, 2018 was $28,639. The notes bear interest at 8% and are due on demand.

 

 

NOTE 4 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.

 

 6 

 

FORWARD LOOKING STATEMENTS

 

The Securities and Exchange Commission (“SEC”) encourages companies to disclose forward-looking information so that investors can better understand future prospects and make informed investment decisions. This report contains these types of statements. Words such as “may,” “intend,” “expect,” “believe,” “anticipate,” “estimate,” “project,” or “continue” or comparable terminology used in connection with any discussion of future operating results or financial performance identify forward-looking statements. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. All forward-looking statements reflect our present expectation of future events and are subject to a number of important factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

 

In this report references to “Cancer Capital,” “the Company,” “we,” “us,” and “our” refer to Cancer Capital Corp.

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Executive Overview

 

We have not recorded revenues for the past two fiscal years and we are dependent upon financing to continue basic operations. Management intends to rely upon advances or loans from management, significant stockholders or third parties to meet our cash requirements, but we have not entered into written agreements guaranteeing funds and, therefore, no one is obligated to provide funds to us in the future. These factors raise doubt as to our ability to continue as a going concern. Our plan is to combine with an operating company to generate revenue.

 

As of the date of this report, our management has not had any discussions with any representative of any other entity regarding a business combination with us. Any target business that is selected may be a financially unstable company or an entity in its early stages of development or growth, including entities without established records of sales or earnings. In that event, we will be subject to numerous risks inherent in the business and operations of financially unstable and early stage or potential emerging growth companies. In addition, we may effect a business combination with an entity in an industry characterized by a high level of risk, and, although our management will endeavor to evaluate the risks inherent in a particular target business, there can be no assurance that we will properly ascertain or assess all significant risks. In addition, any business combination or transaction will likely result in a significant issuance of shares and substantial dilution to present stockholders of the Company.

 

We anticipate that the selection of a business opportunity will be complex and extremely risky. Because of general economic conditions, rapid technological advances being made in some industries and shortages of available capital, our management believes that there are numerous firms seeking the perceived benefits of becoming a publicly traded corporation. Such perceived benefits of becoming a publicly traded corporation include, among other things, facilitating or improving the terms on which additional equity financing may be obtained, providing liquidity for the principals of and investors in a business, creating a means for providing incentive stock options or similar benefits to key employees, and offering greater flexibility in structuring acquisitions, joint ventures and the like through the issuance of securities. Potentially available business combinations may occur in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex.

 

If we obtain a business opportunity, then it may be necessary to raise additional capital. We anticipate that we will sell our common stock to raise this additional capital. We expect that we would issue such stock pursuant to exemptions to the registration requirements provided by federal and state securities laws. The purchasers and manner of issuance will be determined according to our financial needs and the available exemptions to the registration requirements of the Securities Act of 1933. We do not currently intend to make a public offering of our stock. We also note that if we issue more shares of our common stock, then our stockholders may experience dilution in the value per share of their common stock.

 

 7 

 

Liquidity and Capital Resources

 

We have not recorded revenues from operations since inception and we have not established an ongoing source of revenue sufficient to cover our operating costs. We have relied primarily upon related and third parties to provide and pay for professional and operational expenses. At March 31, 2018 we had $178 cash compared to $315 at December 31, 2017. At March 31, 2018 total liabilities increased to $253,172 compared to $243,936 at December 31, 2017. This increase in total liabilities primarily represents accrued interest and accounts payable for consulting services and professional services provided by or paid for by a stockholder and third parties.

 

We intend to obtain capital from management, significant stockholders and/or third parties to cover minimal operations; however, there is no assurance that additional funding will be available. Our ability to continue as a going concern during the long term is dependent upon our ability to find a suitable business opportunity and acquire or enter into a merger with such company. The type of business opportunity with which we acquire or merge will affect our profitability for the long term.

 

During the next 12 months we anticipate incurring additional costs related to the filing of Exchange Act reports. We believe we will be able to meet these costs through funds provided by management, significant stockholders and/or third parties. We may also rely on the issuance of our common stock in lieu of cash to convert debt or pay for expenses.

 

Results of Operations

 

We did not record revenues in either 2018 or 2017. General and administrative expense increased to $5,712 for the three months ended March 31, 2018 (“2018 first quarter”) compared to $5,650 for the three months ended March 31, 2017 (“2017 first quarter”).

 

Total other expense increased to $3,661 for the 2018 first quarter compared to $3,393 for the 2017 first quarter. Total other expense represents accrued interest related to notes payable.

 

Our net loss increased to $9,373 for the 2018 first quarter compared to $9,043 for the 2017 first quarter. Management expects net losses to continue until we acquire or merge with a business opportunity.

 

Commitments and Obligations

 

At March 31, 2018 we recorded notes payable totaling $82,575 and notes payable-related party of $100,525. All of the notes payable are non-collateralized, carry interest at 8% and are due on demand. Total accrued interest on all notes payable was $57,897 at March 31, 2018.

 

At March 31, 2018 accounts payable increased to $12,175 with $3,475 due to vendors and $2,100 paid for consulting services and professional services provided by or paid for by a stockholder and third parties.

 

As of March 31, 2018, two lenders represent in excess of 95% of our accounts and notes payable.

 

Off-Balance Sheet Arrangements

 

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

 

Critical Accounting Policies

 

We qualify as an emerging growth company as that term is used in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). A company qualifies as an emerging growth company if it has total annual gross revenues of less than $1.07 billion during its most recently completed fiscal year and, as of December 8, 2011, had not sold common equity securities under a registration statement.

 

Since we qualify as an “emerging growth company” under the JOBS Act we are permitted to, and intend to, rely on exemptions from certain disclosure requirements. For so long as we are an emerging growth company, among other things, we will not be required to:

 

•Have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;

 

•Submit certain executive compensation matters to shareholder advisory votes, such as “say-on-pay” and “say-on-frequency”;

 

•Obtain shareholder approval of any golden parachute payments not previously approved; and

 

•Disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief Executives compensation to median employee compensation.

 

In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.

 

 8 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our filings under the Exchange Act is recorded, processed, summarized and reported within the periods specified in the rules and forms of the SEC. This information is accumulated to allow our management to make timely decisions regarding required disclosure. Our President, who serves as our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report and he determined that our disclosure controls and procedures were not effective due to a control deficiency. During the period we did not have additional personnel to allow segregation of duties to ensure the completeness or accuracy of our information. Due to the size and operations of the Company we are unable to remediate this deficiency until we acquire or merge with another company.

 

Changes to Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management conducted an evaluation of our internal control over financial reporting and determined that there were no changes made in our internal control over financial reporting during the quarter ended March 31, 2018 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

 

 9 

 

PART II – OTHER INFORMATION

 

ITEM 6. EXHIBITS

 

Part I Exhibits

No. Description
31.1 Principal Executive Officer Certification
31.2 Principal Financial Officer Certification
32.1 Section 1350 Certification

 

Part II Exhibits

No.    Description
3(i)

Wyoming Articles of Domestication for Cancer Capital, dated April 28, 2016 (Incorporated by reference to exhibit 3(i) to Form 10-Q, filed May 13, 2016)

3(ii)

Bylaws of Cancer Capital, dated May 2, 2016 (Incorporated by reference to exhibit 3(ii) to Form 10-Q, filed May 13, 2016)

101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Calculation Linkbase Document
101.CAL XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Label Linkbase Document
101.PRE XBRL Taxonomy Presentation Linkbase Document

 

 10 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Date: May 10, 2018

CANCER CAPITAL CORP.

 

By:   /s/ John W. Peters                

John W. Peters

President and Director

Principal Financial Officer

 

 

11

 EX-31.1 2 cncl0503form10qexh31_1.htm EXHIBIT 31.1

Exhibit 31.1

 

PRINCIPAL EXECUTIVE OFFICER CERTIFICATION

 

I, John W. Peters, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Cancer Capital Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: May 10, 2018

 

/s/ John W. Peters                

John W. Peters

Principal Executive Officer

 EX-31.2 3 cncl0503form10qexh31_2.htm EXHIBIT 31.2

Exhibit 31.2

 

PRINCIPAL FINANCIAL OFFICER CERTIFICATION

 

I, John W. Peters, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Cancer Capital Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: May 10, 2018

 

/s/ John W. Peters                

John W. Peters

Principal Financial Officer

 EX-32.1 4 cncl0503form10qexh32_1.htm EXHIBIT 32.1

Exhibit 32.1

 

 

CANCER CAPITAL CORP.

 

CERTIFICATION OF PERIODIC REPORT

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

18 U.S.C. Section 1350

 

The undersigned executive officer of Cancer Capital Corp. certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

a.the quarterly report on Form 10-Q of Cancer Capital Corp. for the quarter ended March 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

b.the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Cancer Capital Corp.

 

 

 

Date: May 10, 2018

 

 

/s/ John W. Peters                

John W. Peters

Principal Executive Officer

Principal Financial Officer

 EX-101.INS 5 cncl-20180331.xml XBRL INSTANCE FILE 0001130889 2018-01-01 2018-03-31 0001130889 2018-05-08 0001130889 2018-03-31 0001130889 2017-12-31 0001130889 2017-01-01 2017-03-31 0001130889 2016-12-31 0001130889 2017-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CANCER CAPITAL CORP 0001130889 10-Q 2018-03-31 false --12-31 No No Yes Smaller Reporting Company Q1 2018 6150000 0.001 0.001 20000000 20000000 6150000 6150000 6150000 6150000 <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">NOTE 1 &#8211; BASIS OF FINANCIAL STATEMENT PRESENTATION</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company&#8217;s audited financial statements and notes thereto included in its December 31, 2017 Annual Report on Form 10-K. Operating results for the three months ended March 31, 2018 are not necessarily indicative of the results to be expected for year ending December 31, 2018.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">NOTE 4 &#8211; SUBSEQUENT EVENTS</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">NOTE 2 &#8211; GOING CONCERN</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management&#8217;s plan to acquire or merge with other operating companies.</p> 178 315 178 315 178 315 625 475 253172 243936 253172 243936 29258 27607 28639 26629 82575 82575 100525 100525 3475 8700 6600 178 315 -252994 -243621 -306194 -296821 47050 47050 6150 6150 5712 5650 5712 5650 -5712 -5650 2010 1832 1651 1561 3661 3393 -9373 -9043 -9373 -9043 0.00 0.00 6150000 6150000 -137 -150 1651 1561 2010 1832 3475 3400 2100 2100 -137 -150 <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">NOTE 3 &#8211; RELATED PARTY TRANSACTIONS</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the quarter ended March 31, 2018, a shareholder invoiced the Company for consulting, administrative and professional services and out-of-pocket costs provided or paid on behalf of the Company totaling $2,100. Notes payable &#8211; related party at March 31, 2018 were $100,525. Accrued interest at March 31, 2018 was $28,639. The notes bear interest at 8% and are due on demand.</p> 2100 28639 0.08 EX-101.SCH 6 cncl-20180331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cncl-20180331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cncl-20180331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cncl-20180331_lab.xml XBRL LABEL FILE Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash Total current assets Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable - related party Accounts payable Notes payable - related party Notes payable Accrued interest - related party Accrued interest Total current liabilities Total liabilities STOCKHOLDERS' DEFICIT Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding Additional paid-in capital Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Expenses General and administrative Total expenses Loss from operations before other expense Other income (expense), non-operating Interest expense - related party Interest expense Total other expense Loss from operations before taxes Taxes Net loss Net loss per share Weighted average shares outstanding Statement of Cash Flows [Abstract] Cash Flows from Operating Activities Net Loss Adjustments to reconcile net loss to cash provided (used) by operating activities: Expenses paid by related party Changes in assets and liabilities: Increase in Accounts payable Increase in Accrued interest - related party Increase in Accrued interest Net cash provided (used) by operating activities Cash Flows from Investing Activities Net cash provided by investing activities Cash Flows from Financing Activities Net cash provided by financing activities Increase (decrease) in cash Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental Cash Flow Information: Cash paid for interest Cash paid for income taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] BASIS OF FINANCIAL STATEMENT PRESENTATION GOING CONCERN Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Amounts owed to related party Accrued interest Interest rate on notes payable Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Costs and Expenses Operating Income (Loss) Interest Expense, Related Party Interest Expense Other Cost and Expense, Operating Income (Loss) from Continuing Operations before Income Taxes, Domestic Net Cash Provided by (Used in) Operating Activities Cash and Cash Equivalents, Period Increase (Decrease) Accrued Liabilities, Current EX-101.PRE 10 cncl-20180331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2018
May 08, 2018
Document And Entity Information    
Entity Registrant Name CANCER CAPITAL CORP  
Entity Central Index Key 0001130889  
Document Type 10-Q  
Document Period End Date Mar. 31, 2018  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   6,150,000
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2018  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2018
Dec. 31, 2017
CURRENT ASSETS    
Cash $ 178 $ 315
Total current assets 178 315
Total assets 178 315
CURRENT LIABILITIES    
Accounts payable - related party 8,700 6,600
Accounts payable 3,475
Notes payable - related party 100,525 100,525
Notes payable 82,575 82,575
Accrued interest - related party 28,639 26,629
Accrued interest 29,258 27,607
Total current liabilities 253,172 243,936
Total liabilities 253,172 243,936
STOCKHOLDERS' DEFICIT    
Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding 6,150 6,150
Additional paid-in capital 47,050 47,050
Accumulated deficit (306,194) (296,821)
Total stockholders' deficit (252,994) (243,621)
Total liabilities and stockholders' deficit $ 178 $ 315
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2018
Dec. 31, 2017
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 20,000,000 20,000,000
Common stock, shares issued 6,150,000 6,150,000
Common stock, shares outstanding 6,150,000 6,150,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Revenues
Expenses    
General and administrative 5,712 5,650
Total expenses 5,712 5,650
Loss from operations before other expense (5,712) (5,650)
Other income (expense), non-operating    
Interest expense - related party (2,010) (1,832)
Interest expense (1,651) (1,561)
Total other expense (3,661) (3,393)
Loss from operations before taxes (9,373) (9,043)
Taxes
Net loss $ (9,373) $ (9,043)
Net loss per share $ 0.00 $ 0.00
Weighted average shares outstanding 6,150,000 6,150,000
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash Flows from Operating Activities    
Net Loss $ (9,373) $ (9,043)
Adjustments to reconcile net loss to cash provided (used) by operating activities:    
Expenses paid by related party 2,100 2,100
Changes in assets and liabilities:    
Increase in Accounts payable 3,475 3,400
Increase in Accrued interest - related party 2,010 1,832
Increase in Accrued interest 1,651 1,561
Net cash provided (used) by operating activities (137) (150)
Cash Flows from Investing Activities    
Net cash provided by investing activities
Cash Flows from Financing Activities    
Net cash provided by financing activities
Increase (decrease) in cash (137) (150)
Cash and cash equivalents at beginning of period 315 625
Cash and cash equivalents at end of period 178 475
Supplemental Cash Flow Information:    
Cash paid for interest
Cash paid for income taxes
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
BASIS OF FINANCIAL STATEMENT PRESENTATION
 3 Months Ended
Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF FINANCIAL STATEMENT PRESENTATION

NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its December 31, 2017 Annual Report on Form 10-K. Operating results for the three months ended March 31, 2018 are not necessarily indicative of the results to be expected for year ending December 31, 2018.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOING CONCERN
 3 Months Ended
Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 2 – GOING CONCERN

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
RELATED PARTY TRANSACTIONS
 3 Months Ended
Mar. 31, 2018
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 3 – RELATED PARTY TRANSACTIONS

 

During the quarter ended March 31, 2018, a shareholder invoiced the Company for consulting, administrative and professional services and out-of-pocket costs provided or paid on behalf of the Company totaling $2,100. Notes payable – related party at March 31, 2018 were $100,525. Accrued interest at March 31, 2018 was $28,639. The notes bear interest at 8% and are due on demand.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUBSEQUENT EVENTS
 3 Months Ended
Mar. 31, 2018
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 4 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Related Party Transactions [Abstract]    
Amounts owed to related party $ 2,100  
Notes payable - related party 100,525 $ 100,525
Accrued interest $ 28,639  
Interest rate on notes payable 8.00%  
EXCEL 21 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( %IFJDP?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ 6F:J3&;S"V"" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGB06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " !:9JI,=(SQQ^X K @ $0 &1O8U!R;W!S+V-O M&ULS9+!2L0P$(9?17)O)^FZ(J';B^))07!!\1:2V=U@TX1DI-VW-XV[ M740?P&-F_GSS#4RK@]0^XG/T 2-93%>3ZX*,7?/B,?8$9#=BC MPX$2B%H Z^:)X3CU+5P ,XPPNO1=0+,02_5/;.D .R6G9)?4.([UN"JYO(. MMZ?'E[)N98=$:M"8?R4KZ1APP\Z37U=W]]L'UC5>-W=E_;'P6[%KX=1?=%U!+ P04 " !:9JI,F5R<(Q & "<)P M$P 'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03 M621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS M[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C( MWXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU M+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=* MY \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_ MT=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=R MSTS0LS0[=R M2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZ MG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCR MHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)2 M56 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYE ML<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7G MFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5 M' 86%S+D4.Z2D 83 >LX=SFWJXPD6L_UC6'ODR MWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\ MU*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHS MU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\! M4$L#!!0 ( %IFJDSEE&G&PO=V]R:W-H965T&UL?5;;CILP$/T5Q ?+S@^U1[2AI=0FB'H\Z)$VC;:D_/@U&?5G34U!'STRH M'X@D1<[9X/'Q;?5$)P5ZCM1AEGK1G)W94]$*M?HHPCQX:#,3XC B\ *!9D2@ M;,\"&!(X8(>._Q4XNH@(%HC "")#CQ;T&*;'(#TV]'A!3ZP##PQ45N(91Y%I M@J P2LJ<*DCMY)Q9'V,)LRR&%.4A.JW(@47 M/7*K'MMY-F'2)68MT>":1VY)8R?14B<@'"X29=0)%OVBI?QF6JOP2G;O3%]? MK,[M>X]-O_D+'WO_5\)O=2>\,Y.J:YG>&PO=V]R:W-H965T&ULC9=?;YLP%,6_"N*]Q3;&0)5$6IFF M3=JDJE.W9YHX"2I@!D[2??N9/T7@>TGV4K!SSO7OXN34K"ZJ?FN.4FKGOM:X>/*_9'F61-O>JDJ7Y9*_J(M5F6!^\IJIENNM,1>XQ0H17I%GI;E;= MW%.]6:F3SK-2/M5.6DF]T[;RJM2;^W@VV[MDI9(YG*K MVQ*IN9QE(O.\K60X_@Q%W7'-UCB]_ZC^I6O>-/.:-C)1^>]LIX]K-W*=G=RG MIUP_J\M7.304N,[0_7=YEKF1MR1FC:W*F^ZOLSTU6A5#%8-2I._]-2N[ZV6H M_V'##6PPL-% ^56#/QA\R^#U9%VKGU.=;E:UNCAUOUM5VGXIZ(-O'N:VG>R> M7?>9Z;8QL^<-"U?>N:TS2!Y["9M*YHH$442CQ#/KCQ ,A6"=WY_Z8]SOHWZ_ M\_.)WR=6$[TD["1E)Z%A9+4!-3X-< Z."A5@D;%F"R818RB6*!QME@(?;R31H9@O%++!_C)@L%"1< MX,&#DL*DY'9"#9K90H%/0Q#ZB([[\=+WF>*126%F? H MI3 #N;!Y8)C>^430F-M$B)#%(F)T@0F/50ISE8-C$$S,.Q:P&#)A0NZ+)2:& M9RN#VH2G*%7+H),M[SP!=8X^!;M#:O16\-S"(&=]SV1RXOS%#+Y5.?(-$% HE8E M='.% U!J FF,/V-,-&UIC//^6_0O-G>=RXE(.'#ZNZU4DZ,M\BJHR86J)SY\ MA3&?!'EC\M_A"E3+#8G>H^14VK=77J3B;(RB41AY=6W;V79P*TD\VM8-X6@( M)T/P?T,T&J*% 3LRF^IGHDB1"3YXPGVLGIA_(MA%^C!+,VG/SJ[I;*6>O1;Q MQPQ?39Q1LG>2<"8);Q6'%<5VDF"]_P01KD*$UA_-_(F_[H]6_9'UQW-_L$C" M2;96TEF)O_']A>KP2'7#$J^RQ/Z)H M093<;90&R0K08]T-3[K*D][SQ N>])T\CW6.!\^N@RE//X@XMYWT3ESIFV7_ M_YIS!3JFO]'A&ET1IP&%6IGN!]T7KBZX@>+]6/+P5'>+?U!+ P04 " !: M9JI,^H$ S] " #T"@ & 'AL+W=OJK-4R/FK=S)-$;8^\8NI.-+PV=_9"5DR;J3PD MJI&<[9RI*I,L36E2L:*.5PNW]B!7"W'295'S!QFI4U4Q^7?-2W%9QBA^6W@L M#D=M%Y+5HF$'_I/KI^9!FEG2[[(K*EZK0M21Y/ME?(_F&Y1;@U/\*OA%#<:1 M3>59B!<[^;9;QJDEXB7?:KL%,Y[3R=9MY)L($&](C&;]Q$R M*,(Z"^S9=8!-J" 4CH#!'+#SXZ$_A_T3T#]Q_LG0/_7.()1@ZF5Q4W)%04 * M$F8Q@_T4]-,@/DV]+%H)<9*Z.RCD/PU 1$D*D^0@21Z2((\D_Q\20#1*,@5) MIB&)%V0]#8)\ E @U2C+#&29!<^78MB/4OA33<-L)OZWFH:@68J\%V$#R= 4 M9R,\(Z4#A3Q![4! ($J0SP/)"!VI,P@L-/<% MER6$0Y[7,_&<*C:4'[2H5/W@>>WV*$K>WLM:5/J; MO6Q*KO2P.7AMW0B^,Z2R\)COQU[)\\I=+_%V+ M0EZ6+KCO$\_YX:BZ"6^UJ/E!_!#J9_W4Z)$W5MGEI:C:7%9.(_9+]Q$>-LP0 M#.)7+B[MY-[IK+Q(^=H-ONZ6KM\I$H78JJX$UY>SV(BBZ"II'7^&HNZX9D>< MWK]7_VS,:S,OO!4;6?S.=^JX=%/7V8D]/Q7J65Z^B,%0Y#J#^V_B+ H-[Y3H M-;:R:,VGLSVU2I9#%2VEY&_]-:_,]3+4?Z?1!#80V$C0:]\B! ,A^""$QGRO MS%C]Q!5?+1IY<9K^:=6\.Q3P$.C-W':39N_,=]IMJV?/JX0MO'-79X"L>PB; M0&!$>+KXN *C5E@S1+<6V&!$%-,K!*2'P/"#J8> YHXEH?DSR8^PEMKSTD&BBDH'O6U;^ [I2DI!* M$NPDH?DIR4^QD]1RDB*103C9KMX)!9ISDI%*,JPDLY1D>+M\L/<4@R -&*T$ M?/IU]9&6U+??5Q^O$T=@B:%043SS9L-,> !6 [8:0.O<09#8:BA4-/.4@ R: M1V#HQ*5SNTL'"0383V#[P9@@MMW\$8[.4F MYEH)'4F ,RFU,PEPWE"GA$+-GA(ZEB#!:A);38(S ^Q<(4 QF\EJH",.<,:E M=L8!SB^P@W!#@,*YWPV@0PXR?.(RN@*CLXGA;,KL;"(PZ,3=QEPKH7.)X5S* M[%PB,%C)34ROQ)MT6J5H#J8I;9VM/%6J:VHFLV/C^\BZ3LV:7^N&N&]?/\KT MW?1WWASRJG5>I-)]H.G6]E(JH27Z]_J9'W4#/PX*L5?=;:+OF[Z+[0=*UD.' M[HU_$U;_ %!+ P04 " !:9JI,G,Q9Z*\! #. P & 'AL+W=OSD8NUS=+[4!=U%0:"@"I%!X'&%!U J$J&,7S,G74I&X-J^L7]*O6,O M%^'AP:J?L@Y=0=]34D,C!A4>[?@9YG[>4#(W_Q6NH# ]*L$:E54^?4DU^&#U MS()2M'B93FG2.<[\-]@V@,\ _@K ID))^4<11)D[.Q(WS;X7\8KW1XZSJ6(P MC2+]0_$>H]?R \_9-?+,*:L_3??Q-GS;]FW"M M-)Y<;,!;3;-OK V 2G9WN#X=/J[%4="$:+Y#VTTK-CG!]O/K8&PO=V]R:W-H965T&UL?5/;;MLP#/T501]0)4K:;8%MH&E1;, &!!W6/2LV;0O5Q9/DN/O[ M4;+C&9VQ%XND>0X/*2H;K'OU+4 @;UH9G],VA.[ F"];T,+?V X,_JFMTR*@ MZQKF.P>B2B"M&-]L[I@6TM B2[&3*S+;!R4-G!SQO=;"_3Z"LD-.M_0:>)9- M&V* %5DG&O@.X4=W6%"*%F_C*4TZ MAXG_"EL'\ G WP'86"@I?Q1!%)FS W'C[#L1KWA[X#B;,@;3*-(_%.\Q>BD^ MW6;L$GFFE..8PAE6"+>6IP3=HD3TK;F[3%B^B\K/<\W]'C8_X>(/4$L#!!0 ( %IF MJDQ>4#+8M $ ,X# 8 >&PO=V]R:W-H965T&UL?5-A M;]L@$/TKB!]0$I*N:61;:CI-F[1)4:=UGXE]ME&!\P#'W;\?8->S-JM?@#O> MNWMW'-F ]L6U )Z\:F5<3EOONR-CKFQ!"W>#'9AP4Z/5P@?3-LQU%D252%HQ MOME\8%I(0XLL^WZ)]2[:&6BW#PB.JGK'R;TP,E%=2B5_X) MA\\PU7-+R53\5[B""O"H).0H4;FTDK)W'O44)4C1XG7.D?Q.VD<:1"_KPJJGW-:*'H&1S M$\:G#9]K-A34/A[OPMF.(S8:'KOI][#Y"Q=_ %!+ P04 " !:9JI,D1?5 MDK(! #2 P & 'AL+W=OK5K] LPP[\V;8/@E31PML0-6@O[XP0*QX+NZ(OC0;:=CPY6YKUHX0OXK_W9!HLM M++748)Q$0RPT!;W;'4^'&)\"'B6,;G4FL9(+XE,T/M8%S:(@4%#YR"#"=H5[ M4"H2!1G?9TZZI(S ]?F%_7VJ/=1R$0[N47V3M>\*>DM)#8T8E'_ \0/,];RB M9"[^$UQ!A?"H).2H4+FTDFIP'O7,$J1H\3SMTJ1]G&[XVQFV#> S@"^ VY2' M38F2\G?"BS*W.!([];X7\8EW1QYZ4T5G:D6Z"^)=\%[+79;E[!J)YIC3%,/7 M,4L$"^Q+"KZ5XL3_@O-M^'Y3X3[!][\I_$?^PR;!(1$<_EOB5LR?*MFJIQIL MFZ;)D0H'DR9YY5T&]HZG-_D5/DW[9V%;:1RYH \OF_K?('H(4K*;,$)=^&"+ MH:#Q\?@FG.TT9I/AL9]_$%N^&PO=V]R:W-H965T0U$CT'?#8D2E 8!"FBN.W\,C>Q M(R]S=I6D[>#(/7&E%/,_>R!L*/R-_QYX;NM&Z@ J\Q[7\ /DS_[(U0E-6]>'KN? #;0@(5%)GP&JYP0$( MT8F4C=]C3G^2U,3Y_CW[9U.[JN6$!1P8^=6>95/X6]\[PP5?B7QFPQ<8ZTE\ M;RS^&]R *+AVHC0J1H3Y]:JKD(R.6905BM_LVG9F'>Q-DHTT-R$<">%$4-K_ M(T0C(?H@Q*9XZ\R4^@E+7.:<#1ZW?U:/]3>QV46JF94.FMZ9.U6M4-%;N0FB M'-UTHA&SMYAPCID02&6?)$*7Q#Y%K [-ZG3 M3;IR$P<+-^FZY&T:/;I5,J=*YNCLHIJ]"Y,N1-#L>Z; :_/TA5>Q:V?&SBPZ M39>GT+R'#[@=3=\QK]M.>"&PO M2-V:[I8=SZ_?[[0DD)$@I/8A3JP^?>Z7[W3>6>O8MR16 M]I>3R+GTS?FY#2*1<-O5J5 X66F3<(=?S?K9?/91IU! MHSJ[Y 7%3*RE=8;CWH0G8I=J.)@,1S,V'-R-%X-;-IS.[O8P&D*TX3%$AN(; M^R >]^JW>$QK]%^Z$D9IL"MDU=[6[I<=:/_W4Y)(2>STW,U[NG M*Q[;NM69,?Z"M %,^B*XV2N]T^E?=%[T=S^/;1D#SGX7<=SYJO2#8G/!K58B M9&-K,V'^M7MMH@\Q^DW'R$)N'J%9W'![0_O,(K"I-DZJ-9L[[C++"J-JE[[4 M,[00Z(6P(8Q>:U.+YSSA,9UO!0UUDG)5(RP31"<)JF+N=/"US>:^--@T<]:A M?G!];_B+*!19<(//-84_U?R_>]O'L/'N4"-CE45,WO.8JT! -S0!R\X^*YZ% MTHGP.6KY\_R:G9T^K\D1P:9<7]=8?Y[-1I,%&\SGH\6\=LIMM/MMH1V4#8K\ MX]9"D6::YK-2XNUX\'Y\.UZ,1S6Q@R"@7F99RA_Y,A:PS8@800[QQ;A:^';I M=\ZIP[ZQ*0_$+R=HH5:8>W%RQ>J)[<31(I\0-^AC,MR4R@G(S>;/V/7H9CP<+^KIYLO YF5PVNWU^J0W MN^=Q)MXBC=J]GO]33 _&,Q=I(_\2X5OVJMU_^>104AL)_032^TMI$"*-,0.@ M?LIEV)&*!3R5,*?!65F2Y=X,Q4H&46/NKJ_*N\X M!2H23J*NJ3)/V?F>24N=3_@NH%=H! I\)'42;;T[V'\&2YI]@?OOX2AMXG.8 MK!:PH\CS$!Y%>B#$6W]MC+9D]305QL__(_M9%7[4^ME8!3H16PD''#@3]T)E M#:/E6TIJUK[_*I0@^$ )PL-$*H]*G+RO^3Q/*K&'SZVVEJV,3IC>6KX4@$&" M:62-*6_N7ISZ0YE;>%80/6\SI56G8%7W^KCL007]]WK1+GVS;0?U/&2@X]\: MVE;3QXE JP.G?=\9>.=9MTOQNY#KB SD]Q"_%O]';M( !"C3#T?F9H7>.V!: MAH4- F1*8T\F@VX;#!V$?V36Y:HXC:@%<!HTF5'L#7@ 2F1M]+ '5VEEE2 M;_G(-OG ^$;PFWV9[ELNW3J8&<.(JS5U U5,=E\)E=99XX]BQ,:"G,.5[\SH M7=H?FI^'[C9Y^T><]KT(C]4]I'P_PD]E0IC<7#Q>6#$@?ES8:G-QO["-%\]" MD?_K.?-CN(X!O5X4?2](_)E)S!Z?J-RATM=2*9*% DH])/ZA^X*0PKZ;\RQ- M8U^?Z$(;]U2WR%H6>BJ?X:#9FQ>[5+[)-G:K]X/Y>,ZF-^QF/,'N.<;2.5\, M%J./A&KO9J,Y_AXLQM-)K7^;-5?R+Z]E&\N&LCJ68;Z)DS/N")O",/_A"1RH M-*7]\VPR78Q8G_W];Y<7_?Y;=K2:;!$)I$60KT84MZSL="S8],55J4S+;I6) MT&$1;Z&0; *EF2<;9D.Y:+$T,S:CU1V]BKZ;+"XPEA%K0G%^.,!8.IP+8-PM M"AM]"WS+\7L9, A(NUCBC>-2M63E&8.(5UH[!5#.0FQ3Z(X9=7Q%)'%,Q1;$ M6>C;PM825K%DHS]U-_C"A![1/4@7L74^^,$&)R+UDR7O9G!6*S5@+E,R:^N. MK=^03#J1SC6SMED0-?NDZ\-2M7*5&4".*&?D_"%262:MAB!532ML+[U!@P2; MA.\%E0F3BU_%(J!?XKAZV&8/D0RB=BE8IP _>8XF7&'"$E6[!?]A-@7"6MK_ MJ8PX6W%I6+J3V-[J)EV[;! #F6;KJ,(8'HTEL)KULJOA)9TK'FH5*NJW MEDAP'PO,P:XT;6*;]F$M@2L**:Q1(4V.Q% ML@0,*M%P:Z!4!B[Y@P>#Z!M8R_J]SH=N!8O 35F,^Q0B4LM%1@B6Y$]^@I[\ M&$ V8E0^\GE_DKO*\$I?4R'V&\*_9?T6?%M0%9X@=!AXZR#FD1XWA,=>-;4O MNS6H/1U/?F7#*;WLU=JH[W,7FS[WA+;>RQI=2X7:>MJW &FRA"Z44=^TL >) M:D XX;H,S!$8MM9$27A,&)57:DD=@2"6B0]K#I/:_AMB1_M[Z)$;8FKQ0;3H M1YK/ R)28IT[U,_%U7;P;X%TV^>%)R9,Z%>83MZA=L!$EXTIBS:_5]I3H6"K M3("4 V19<>_W&PI545N^($*14DZ@$+-4JPJ4(/A9NF6KH'<'2F8%R1J,#)?X MS69+PMZ. A'J;.D87P*/MTAZ#B ?RRPJ/5EEO\_KC=$-M<_5HEH8\:IV.A_@ MA%:$(F%;WL6^L67.SWVO"4S/2!2-&_=(WB1O;/O2IHI3;/^D+0\ 9&B),RP1 M9EVT^'Q5VD++/#R7QJXSDU>"8.B@Q@G3V!60BBV_6N4O)81HM0Q\X]Q& MD5(,(2,_^R;[='/V:0:@NA)^O%,\!S9>=@D'[Y<7+ M;FW!:#7<0+J>7ERV7[WX9YZF>1M?4@_<[#2X=OES_I@ _B'5D$*M(;_"6F;, M/[^?CSY])N0V^@T_:PDQ1WEAVE&1CNZ/P8G_V)A?XUUK9X(>EKR+[%:,\&*V MI;,LWL#\?T^QT,_=R/A1[L=V_F%/Q7H75QX*26HHX"CD2F40TU#W@RA'$(4* M_O1!9W&8=SB.&J5I#1$21@1^#NX3_0-%R,ZN!7I!;-F$FSQ]#[P$#))\W=4/ M9( ^\M'%D)MR:++_>?FRV^O]O/UX;JV[^A]02P,$% @ 6F:J3$X2[T\P M @ ?@D T !X;"]S='EL97,N>&ULU5;;:MPP$/T5H2TE@1+;FV9+&MO0 M!@*%-@2R#WT+6GML"W1Q97EKY^NKBR^[6TK+MBG)BS5S1CIS9BPDQ8WN&=Q7 M !IUG(DFP976]?L@:+(*.&G.9 W"1 JI.-'&5670U I(WMA%G 7+,%P%G%"! MTUBT_(;K!F6R%3K!RPE"?OVUS"'!#R>OO[527[U"?ER\62S"A].K0_S$!4XQ M\AR?\@1'J[_AI04RR:1"VG31J(LLTCSZ<.0]V^"!AU,AE_%CK)NVR>>X?V\BA:5-.MU!];4XUPOMT[<*>@H)WSNV+* M;]A)7;/^ Z.EX.!K^6W"Z,B$:4S&/*B2BCX:/KM3,@. PF@+2M-L%_FN2+V& M3H^[J2N.U;Q\@9K_=9]+$* (VQ5MMOYS[O)_5GS^[N\ENT/E4/#SZNI32[2W MW0L0>?'$(H/A.-^Y,_9NC E%FY8R3<4@MZ)Y#EZ/O;(3?&O?"VSOX)XO#D.O MR<8\AO;XS=H<"M(R?6=+=,$$S_9G*SQ:3;/6$T6"9_L+Y+3EER[A_.)*?P!0 M2P,$% @ 6F:J3%*)J%*U 0 ,P< \ !X;"]W;W)K8F]O:RYX;6S% MU[;KR%"]0GU MPN:"_X;QAY$\ZR\N/LZ>*A+U=MYTWBE_R>[X= LD4_<24G#?6Q-)Q MMA'8)>W;JV@E?F+B14$SW//L4B-35Y3 BBC*F2QI(RU@I,:-U8< 83EX3%'U M%WQV3:5C+>BV]O.--=5]191^YY-*>J[0 K&B>D'X^;2%CX=T.D$,4&&RLV(&:J)K*@0W)0D?\Q&?/TI&!8DY(.VW=V@^YI:K1@$ " ) M 3 6T-O;G1E;G1?5'EP97-=+GAM;,V6RV[",!!%?P5E6Q$#;>E#A$W; M;8O4_H!K3X@5OV0/%/Z^DP"5BE*)"B)Y$\>^,W>.G9&>BYDM@D]%HRH2S"!:'V'AD\]DSE'RE?0 N8P6 1N>QX@'D.P9EEWO>!0_XR@T9 MLXUFOP+R_CAPJZ$;H%4N61FI+:"K5"OLGN.S"AZZ0;@ 0Q](#:@ZMD=("U(C M:P(ON45H6D>"/*DX6??W8;])<-PGPO&0",=XU.--V8RYX&PO=&AE M;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( %IFJDSEE&G&PO=V]R M:W-H965T&UL4$L! A0#% @ 6F:J3"^==0;L 0 @P4 M !@ ( !X X 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 6F:J3)S,6>BO 0 S@, !@ ( ! M.Q< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M6F:J3)$7U9*R 0 T@, !@ ( !\!P 'AL+W=O !X;"]W;W)K&UL4$L! A0# M% @ 6F:J3#^HR.]:"0 2AP !0 ( !&"$ 'AL+W-H M87)E9%-T&UL4$L! A0#% @ 6F:J3$X2[T\P @ ?@D T M ( !I"H 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL M4$L! A0#% @ 6F:J3!W+H@GY HP< !H ( !X2X M 'AL+U]R96QS+W=O XML 22 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 23 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 25 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 7 62 1 false 0 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://CNCL/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Balance Sheets (Unaudited) Sheet http://CNCL/role/BalanceSheets Condensed Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://CNCL/role/BalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://CNCL/role/StatementsOfOperations Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://CNCL/role/StatementsOfCashFlows Condensed Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Sheet http://CNCL/role/BasisOfFinancialStatementPresentation BASIS OF FINANCIAL STATEMENT PRESENTATION Notes 6 false false R7.htm 00000007 - Disclosure - GOING CONCERN Sheet http://CNCL/role/GoingConcern GOING CONCERN Notes 7 false false R8.htm 00000008 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://CNCL/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 8 false false R9.htm 00000009 - Disclosure - SUBSEQUENT EVENTS Sheet http://CNCL/role/SubsequentEvents SUBSEQUENT EVENTS Notes 9 false false R10.htm 00000010 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://CNCL/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://CNCL/role/RelatedPartyTransactions 10 false false All Reports Book All Reports cncl-20180331.xml cncl-20180331.xsd cncl-20180331_cal.xml cncl-20180331_def.xml cncl-20180331_lab.xml cncl-20180331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 true true ZIP 27 0001554795-18-000117-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001554795-18-000117-xbrl.zip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end